Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,371,601 papers from all fields of science
Search
Sign In
Create Free Account
PARK3 gene
Known as:
PARK3
, Parkinson disease 3 (autosomal dominant, Lewy body)
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
PARK2 gene
PARKINSON DISEASE 3, AUTOSOMAL DOMINANT LEWY BODY (disorder)
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Diets supplemented with Mytilus galloprovincialis from polluted and non-polluted waters and their influence on zinc content in liver of rats loaded with cholesterol.
Iwona Jesion
,
M. Leontowicz
,
+4 authors
S. Gorinstein
2014
Corpus ID: 53518968
Diets supplemented with Mytilus galloprovincialis from polluted and non-polluted waters and their influence on zinc content in…
Expand
2013
2013
Genetic analysis of the F-box only protein 41 gene in Chinese Han patients with Parkinson's disease.
Hui Liang
,
Zhi Song
,
+6 authors
H. Deng
Parkinsonism & Related Disorders
2013
Corpus ID: 10188515
Highly Cited
2003
Highly Cited
2003
A haplotype at the PARK3 locus influences onset age for Parkinson’s disease
Samer Karamohamed
,
A. Destefano
,
+33 authors
Alan G. Herbert
Neurology
2003
Corpus ID: 19364494
Objective: To identify a haplotype influencing onset age for Parkinson’s disease (PD) in the PARK3 region on chromosome 2p13…
Expand
Review
2003
Review
2003
Familial Parkinson’s disease: a hint to elucidate the mechanisms of nigral degeneration
N. Hattori
,
Hirokazu Kobayashi
,
Yasuko Sasaki-Hatano
,
Kenichi Sato
,
Y. Mizuno
Journal of Neurology
2003
Corpus ID: 13017418
Abstract.In the majority of patients with Parkinson’s disease (PD), it is now clear that genetic factors contribute to the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE